Indkaldelse til ekstraordinær generalforsamling i Pharma Equity Group A/S
11. Oktober 2023 06:27 ET
|
Pharma Equity Group A/S
11. oktober 2023 Meddelelse nr. 40 Indkaldelse til ekstraordinær generalforsamling i Pharma Equity Group A/S ("Selskabet") 2. november 2023 kl. 15:00 (dansk tid) hos Wihlborgs kantinerSlotsmarken...
Notice convening the extraordinary general meeting of Pharma Equity Group A/S
11. Oktober 2023 06:27 ET
|
Pharma Equity Group A/S
11 October 2023 Announcement no. 40 Notice convening the extraordinary general meeting of Pharma Equity Group A/S (the "Company") November 2, 2023, at 3 PM CET at Wihlborg's CanteensSlotsmarken...
Status for Selskabets tilgodehavende fra Portinho S.A.
25. September 2023 14:49 ET
|
Pharma Equity Group A/S
25. september 2023 Meddelelse nr. 39 Status for Selskabets tilgodehavende fra Portinho S.A. I det konsoliderede regnskab (med datterselskabet Reponex Pharmaceuticals A/S) pr. 30. juni 2023 har...
Status of the Company's receivables from Portinho S.A.
25. September 2023 14:49 ET
|
Pharma Equity Group A/S
25. September 2023 Announcement no. 39 Status of the Company's receivables from Portinho S.A. In the consolidated financial statement (with the subsidiary Reponex Pharmaceuticals A/S) as of 30...
Consolidated interim report 1 January – 30 June 2023
16. August 2023 02:19 ET
|
Pharma Equity Group A/S
16 August 2023 Announcement no. 38 Consolidated interim report 1 January – 30 June 2023 Key points (H1 2023) On 16 August 2023, the Board of Directors and Executive...
Pharma Equity Group’s datterselskab (Reponex Pharmaceuticals A/S) modtager USPTO meddelelse om udstedelse af patent på behandling med datterselskabets sårhelende lægemiddelkombination.
15. August 2023 07:54 ET
|
Pharma Equity Group A/S
15. August 2023 Selskabsmeddelelse nr. 37 Pharma Equity Group’s datterselskab (Reponex Pharmaceuticals A/S) modtager USPTO meddelelse om udstedelse af patent på behandling med...
Pharma Equity Group’s subsidiary company (Reponex Pharmaceuticals A/S) receives USPTO Notice of Allowance for a method of treatment patent on its topical wound-healing composition.
15. August 2023 07:54 ET
|
Pharma Equity Group A/S
15 August 2023 Announcement no. 37 Pharma Equity Group’s subsidiary company (Reponex Pharmaceuticals A/S) receives USPTO Notice of Allowance for a method of treatment patent on its topical...
Status på selskabets tilgodehavende hos Portinho S.A. med betalingsfrist den 1. juli 2023
30. Juni 2023 11:56 ET
|
Pharma Equity Group A/S
30 juni 2023 Meddelelse nr. 36 Status på selskabets tilgodehavende hos Portinho S.A. med betalingsfrist den 1. juli 2023 I det konsoliderede regnskab (med...
Status of the company's receivables from Portinho S.A. with payment deadline 1 July 2023
30. Juni 2023 11:56 ET
|
Pharma Equity Group A/S
30 June 2023 Announcement no. 36 Status of the company's receivables from Portinho S.A. with payment deadline 1 July 2023 In the consolidated financial statement (with the...
Changes to the Board of Directors in Pharma Equity Group
15. Juni 2023 06:00 ET
|
Pharma Equity Group A/S
15 June 2023 Announcement no. 35 Changes to the Board of Directors in Pharma Equity Group Today, the company has received notice that the Chairman of the Board of Directors, Peter Mørch Eriksen...